Over the last 7 days, the market has remained flat, though it is up 18% over the past year and earnings are forecast to grow by 17% annually. For those looking to invest in smaller or newer companies, penny stocks — despite their vintage name — can still offer surprising value. With solid financial foundations, these stocks have the potential to outperform while offering greater stability.
Let's explore several standout options from the results in the screener.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: JFB Construction Holdings is a U.S.-based company specializing in commercial and residential real estate construction and development, with a market cap of $96.70 million.
Operations: The company's revenue is derived from three primary segments: Commercial ($20.00 million), Residential ($10.26 million), and Real Estate Development ($12.43 million).
Market Cap: $96.7M
JFB Construction Holdings, with a market cap of US$96.70 million, operates in commercial and residential real estate construction and development. Despite reporting second-quarter sales of US$9.07 million, the company remains unprofitable with a net loss of US$4.01 million for the quarter. JFB is debt-free but faces financial challenges with less than a year of cash runway based on current free cash flow trends. The company's stock has experienced high volatility over recent months, though its weekly volatility has decreased from 21% to 12%. Management is relatively experienced with an average tenure of 3.8 years.
Simply Wall St Financial Health Rating: ★★★★★☆
Overview: GoodRx Holdings, Inc. provides consumers in the United States with tools to compare prices and save on prescription drug purchases, with a market cap of approximately $1.20 billion.
Operations: The company's revenue is generated from its Healthcare Software segment, which amounts to $785.23 million.
Market Cap: $1.2B
GoodRx Holdings, with a market cap of US$1.20 billion, has shown resilience in the penny stock space despite facing challenges like declining profit margins and negative earnings growth over the past year. The company reported second-quarter sales of US$200.41 million, down slightly from the previous year. Its financial health is supported by short-term assets exceeding both short and long-term liabilities. Recent executive changes saw Justin Fengler appointed as CFO and Treasurer, which may impact strategic direction positively given his extensive experience within the company. Despite current volatility and low return on equity, GoodRx's debt levels remain satisfactory with coverage by operating cash flow at 41.4%.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Butler National Corporation is involved in the design, engineering, manufacturing, and servicing of aerostructures and aircraft components with a market cap of $274.91 million.
Operations: The company's revenue is primarily derived from its Gaming segment at $37.38 million, followed by Aircraft Modifications at $37.20 million, Special Mission Electronics at $19.22 million, and Aircraft Avionics at $4.17 million.
Market Cap: $274.91M
Butler National Corporation, with a market cap of US$274.91 million, has demonstrated robust financial growth in the penny stock domain. The company reported annual revenue of US$97.97 million, an increase from the previous year, and net income rose to US$21.93 million. Earnings have grown significantly by 74.8% over the past year, outpacing its five-year average growth rate of 27.9%. The company's debt is well-covered by operating cash flow and it holds more cash than total debt. Recent strategic extensions in sports wagering contracts through Boot Hill Casino & Resort bolster its gaming segment's future prospects amid leadership transitions with Adam B. Sefchick as interim CEO following Christopher J. Reedy's retirement due to health reasons.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com